Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
The cancer germline antigens MAGE-A1, MAGE-A3, and NY-ESO-1 can be used to target relapsed or therapy-resistant malignant solid tumors, and previous studies have demonstrated that these antigens can be epigenetically upregulated on the surface of tumor cells following exposure to low-dose demethylat...
Saved in:
| Main Authors: | Deepa Kolaseri Krishnadas, Yali Wang, Kumaran Sundaram, Fanqi Bai, Kenneth G Lucas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-07-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317701309 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autotransplantation of T-lymphocytes as a tool for antigen-specific immunotherapy of oncological diseases
by: A. Yu. Lupatov, et al.
Published: (2018-09-01) -
The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
by: Giorgia Tiberi, et al.
Published: (2025-08-01) -
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01) -
Antigen‐specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis
by: Kaiser Alam, et al.
Published: (2025-01-01) -
Cytotoxic T lymphocytes in regional lymph nodes in colon cancer
by: V. V. Kryukova, et al.
Published: (2025-07-01)